Intellectual Property


Sanofi Files Patent Infringement Suit Against Mylan Over Lantus Generic

Sanofi sued Mylan in the U.S. District Court for the District of New Jersey alleging the generic manufacturer infringed on 18 of its patents covering an insulin pen. Read More

Judge Deals Blow to Boston Scientific in Patent Lawsuit

Boston Scientific Corp. can’t defend itself against a rival devicemaker’s patent-infringement claim by arguing that the rival’s attorney should have made sure a patent examiner fully understood what a document meant when it was invoked in an administrative proceeding, a federal judge ruled. Read More

U.S. Trade Representative Report Has Particular Concern for Device Makers

The U.S. Trade Representative flagged China and India on its latest priority watch list of countries with lax intellectual property protections and counterfeit products, noting special concern for medical devices. Read More

Ivoclar Vivadent Alleges Patent, Trade Violations by GC and GC America

The U.S. International Trade Commission (USITC) announced it will investigate, for patent infringement and tariff violations, certain dental ceramics and related products, and methods of making them. Read More

Supreme Court Ruling Strengthens Patent Holders’ Claims in Infringement Cases

Presumption of validity could make it easier for medical devicemakers to sue for patent infringement. Read More

Patent Outlook Improving, Experts Say at MDMA

Patent troll cases filed against devicemakers have dropped dramatically in the wake of recent legal challenges, an attorney says. Read More

Guidance Creates Two-Step Process for Patent Subject Matter Eligibility

Interim guidance from the U.S. Patent & Trademark Office on patent subject matter eligibility clarifies how the agency will review patent applications in the wake of the Supreme Court’s decisions in Association of Molecular Genetics v. Myriad and Mayo v. Prometheus. Read More

Cerus Wins Extra Year of Patent Protection for Intercept System

The U.S. Patent and Trademark Office has extended for one year the patent on a novel device that reduces pathogens in blood platelets and plasma while the FDA reviews its use in treating Ebola patients. Read More

Canadian Device Safety Law Boosts Penalties, Jeopardizes Trade Secrets

A sweeping rewrite of Canada’s drug safety law that authorizes the government to order recalls and require labeling changes and postmarket studies could spell new worries for devicemakers because it also allows for the release of confidential business information on unsafe products. Read More

High Court Hands Down Rulings In Nautilus, Limelight Patent Cases

The U.S. Supreme Court ruled Monday on two patent cases with potential ramifications for medical devicemakers. Read More